🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The purpose of this study was to assess the safety and immunogenicity of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-05-26
Trial ID
NCT04535037
Treatments Being Tested
This is a study in a large number of healthy children less than 3 years old...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-28
Trial ID
NCT00466947
The study investigated safety profile and the antibody responses to an expe...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00771849
This is a randomized double-blind controlled study and was performed to com...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02808637
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
Primary Objective: To demonstrate the non-inferiority of the SHAN6™ vaccin...
Status
Completed
Location
Investigational Site Number 7640003
Start Date
2020-06-28
Trial ID
NCT04429295
Treatments Being Tested
The purpose of this booster study is to evaluate, in subjects primed in the...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-01
Trial ID
NCT00627458
Treatments Being Tested
This study is designed to study the immunogenicity and safety of sIPV co-ad...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Start Date
2023-05-22
Trial ID
NCT05850364
Treatments Being Tested
The objective of this study was to evaluate the safety and immunogenicity o...
Status
Completed
Location
Beijing Huaxin Hospital
Start Date
2011-11
Trial ID
NCT01761136
Treatments Being Tested